Solution International Nordics Q2 FY26 loss after financial items widens to SEK 1.35 million; net sales total SEK 29.79 million
Reuters2026/08/27 09:08- Solution International Nordics posted Q2 2026 net sales of SEK 29.8 million; EBITDA totaled SEK 1.74 million.
- Loss after financial items widened to SEK 1.35 million; EPS was -SEK 0.03.
- H1 net sales reached SEK 57.31 million; EBITDA was SEK 2.49 million.
- H1 loss after financial items widened to SEK 3.61 million; equity ratio stood at -69%.
- Management cited expanded Kruidvat distribution in the Netherlands, a Studio 100 Benelux license deal, e-commerce revenue up more than doubled (154%) year-to-date.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas
A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.
Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260
10-Yr Benchmark Govt Yields - Germany vs Other Nations
Crypto prices
More
